DE68908119D1 - Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon. - Google Patents
Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon.Info
- Publication number
- DE68908119D1 DE68908119D1 DE8989312404T DE68908119T DE68908119D1 DE 68908119 D1 DE68908119 D1 DE 68908119D1 DE 8989312404 T DE8989312404 T DE 8989312404T DE 68908119 T DE68908119 T DE 68908119T DE 68908119 D1 DE68908119 D1 DE 68908119D1
- Authority
- DE
- Germany
- Prior art keywords
- intralesion
- recombinant human
- treatment
- cell carcinomas
- human alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27831588A | 1988-12-01 | 1988-12-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE68908119D1 true DE68908119D1 (de) | 1993-09-09 |
DE68908119T2 DE68908119T2 (de) | 1993-11-18 |
Family
ID=23064525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE89312404T Expired - Fee Related DE68908119T2 (de) | 1988-12-01 | 1989-11-29 | Arzneimittel zur Intralesionsbehandlung von schuppenartigem Zellkarzinomen mit rekombinantem human-alpha-Interferon. |
Country Status (14)
Country | Link |
---|---|
EP (2) | EP0372809B1 (de) |
JP (1) | JPH0647556B2 (de) |
KR (1) | KR950011889B1 (de) |
AT (1) | ATE92333T1 (de) |
AU (1) | AU634511B2 (de) |
CA (1) | CA2004202C (de) |
DE (1) | DE68908119T2 (de) |
DK (1) | DK103891D0 (de) |
ES (1) | ES2058555T3 (de) |
IE (1) | IE63121B1 (de) |
IL (1) | IL92495A (de) |
MY (1) | MY107071A (de) |
WO (1) | WO1990006135A1 (de) |
ZA (1) | ZA899113B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992010207A1 (en) * | 1990-12-14 | 1992-06-25 | Schering Corporation | Oral administration of alpha interferon to treat lung malignancies |
IL100415A0 (en) * | 1990-12-21 | 1992-09-06 | Schering Corp | Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases |
ATE229343T1 (de) * | 1995-10-04 | 2002-12-15 | Schering Corp | Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs |
US7294332B2 (en) | 1995-10-04 | 2007-11-13 | Schering Corporation | Combination therapy (temozolomide and α-IFN) for advanced cancer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3278234D1 (en) * | 1981-10-13 | 1988-04-21 | Exovir Inc | Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis |
PH26198A (en) * | 1986-05-27 | 1992-03-18 | Schering Corp | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon |
-
1989
- 1989-11-29 DE DE89312404T patent/DE68908119T2/de not_active Expired - Fee Related
- 1989-11-29 EP EP89312404A patent/EP0372809B1/de not_active Expired - Lifetime
- 1989-11-29 KR KR1019900701665A patent/KR950011889B1/ko not_active IP Right Cessation
- 1989-11-29 IL IL9249589A patent/IL92495A/en not_active IP Right Cessation
- 1989-11-29 AU AU48025/90A patent/AU634511B2/en not_active Ceased
- 1989-11-29 ES ES89312404T patent/ES2058555T3/es not_active Expired - Lifetime
- 1989-11-29 WO PCT/US1989/005287 patent/WO1990006135A1/en not_active Application Discontinuation
- 1989-11-29 CA CA002004202A patent/CA2004202C/en not_active Expired - Fee Related
- 1989-11-29 EP EP90900655A patent/EP0446279A1/de active Pending
- 1989-11-29 AT AT89312404T patent/ATE92333T1/de not_active IP Right Cessation
- 1989-11-29 ZA ZA899113A patent/ZA899113B/xx unknown
- 1989-11-29 MY MYPI89001661A patent/MY107071A/en unknown
- 1989-11-29 JP JP2501299A patent/JPH0647556B2/ja not_active Expired - Lifetime
- 1989-11-30 IE IE382889A patent/IE63121B1/en not_active IP Right Cessation
-
1991
- 1991-05-31 DK DK911038A patent/DK103891D0/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH04500678A (ja) | 1992-02-06 |
IL92495A (en) | 1995-05-26 |
KR900701311A (ko) | 1990-12-01 |
ATE92333T1 (de) | 1993-08-15 |
IL92495A0 (en) | 1990-08-31 |
EP0372809B1 (de) | 1993-08-04 |
WO1990006135A1 (en) | 1990-06-14 |
AU634511B2 (en) | 1993-02-25 |
DK103891A (da) | 1991-05-31 |
IE63121B1 (en) | 1995-03-22 |
ES2058555T3 (es) | 1994-11-01 |
ZA899113B (en) | 1990-08-29 |
MY107071A (en) | 1995-09-30 |
AU4802590A (en) | 1990-06-26 |
EP0372809A1 (de) | 1990-06-13 |
KR950011889B1 (ko) | 1995-10-12 |
DE68908119T2 (de) | 1993-11-18 |
CA2004202C (en) | 2001-02-13 |
IE893828L (en) | 1990-06-01 |
CA2004202A1 (en) | 1990-06-01 |
EP0446279A1 (de) | 1991-09-18 |
DK103891D0 (da) | 1991-05-31 |
JPH0647556B2 (ja) | 1994-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3880766D1 (de) | Konjugate von interferon alpha mit immunglobulinen. | |
BG60253B1 (bg) | Човешки тъканен плазминогенен активатор | |
NO176665C (no) | Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav | |
DE3583849D1 (de) | Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung. | |
AU7679787A (en) | Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventive or curative treatment of the corresponding tumor | |
IL72985A0 (en) | Homogenous immune interferon fragment,its manufacture and pharmaceutical compositions containing it | |
GB8805792D0 (en) | Medicaments | |
DE68908119D1 (de) | Arzneimittel zur intralesionsbehandlung von schuppenartigem zellkarzinomen mit rekombinantem human-alpha-interferon. | |
ES2115582T3 (es) | Preparacion y aplicaciones de interferon-gamma. | |
DE3861494D1 (de) | Pharmazeutische zusammensetzung zur behandlung von tumoren. | |
ES2061496T3 (es) | Tratamiento intralesional del carcinoma de celulas basales con alfa-interferon humano recombinante. | |
NO864932L (no) | Anordning for injeksjon av behandlingsprodukter i broenner. | |
ES2039276T3 (es) | Uso de una combinacion de interferon gamma e interferon alfa para la preparacion de un medicamento para el tratamiento de ciertas leucemias. | |
DE3750248D1 (de) | Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon. | |
EP0278715A3 (de) | Verwendung von menschlichem Gamma-Interferon für die Behandlung von Basalzell-Karzinomen | |
DE69005837D1 (de) | Verwendung bestimmter gamma-Interferone zur Behandlung von Krebs des Ovars. | |
NO900121L (no) | Probursin. | |
ATE88090T1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |